Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Johan Lombaard

2PUBLICATIONS
16CO-AUTHORS
Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Aug 13, 2025
The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans.

Rosie Mngqibisa, Yashna Singh, Catherine Orrell

|Dec 06, 2021
Phase 2 Open-Label Study of Long-Term Safety, Tolerability, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive Adolescents Living with HIV-1.

Johan Lombaard, Francis Ssali, Puthanakit Thanyawee

Pageof 1

Frequent Collaborators

1 joint publications

Rosie Mngqibisa

1 joint publications

Yashna Singh

1 joint publications

Catherine Orrell

1 joint publications

Sandy Griffith

1 joint publications

Conn Harrington

1 joint publications

Ronald D'Amico

1 joint publications

William Spreen

1 joint publications

Marty St Clair

1 joint publications

Christine Latham

1 joint publications

Louise Garside

Frequent Collaborators

1 joint publications

Rosie Mngqibisa

1 joint publications

Yashna Singh

1 joint publications

Catherine Orrell

1 joint publications

Sandy Griffith

Top Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

1.5K
Humanized NOD/SCID/IL2r&#947;<sup>null</sup> (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2r&#947;<sup>null</sup> (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on : Jan 07, 2019

15.9K
See more related videos

Top Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

1.5K
Humanized NOD/SCID/IL2r&#947;<sup>null</sup> (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2r&#947;<sup>null</sup> (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on : Jan 07, 2019

15.9K
See more related videos